Clinicopathological significance of claudin-4 in gastric carcinoma

World Journal of Surgical Oncology

Volumn 11, Issue , 2013, Pages

  Zhu, Jin Liang ^a   Gao, Peng ^a   Wang, Zhen Ning ^a   Song, Yong Xi ^a   Li, Ai Lin ^a   Xu, Ying Ying ^a   Wang, Mei Xian ^a   Xu, Hui Mian ^a  

^a CHINA MEDICAL UNIVERSITY   (China)

Author keywords

Claudin 4; Gastric carcinoma; Tight junctions

Indexed keywords

CLAUDIN 4;

ADULT; AGED; ARTICLE; CANCER PROGNOSIS; CANCER SIZE; CANCER SPECIFIC SURVIVAL; CANCER STAGING; CAUSE SPECIFIC SURVIVAL; CONTROLLED STUDY; FEMALE; GASTROINTESTINAL DYSPLASIA; HISTOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; INTESTINE METAPLASIA; LYMPH NODE DISSECTION; LYMPH NODE METASTASIS; LYMPH VESSEL METASTASIS; MAJOR CLINICAL STUDY; MALE; OVERALL SURVIVAL; PROTEIN EXPRESSION; STOMACH; STOMACH ADENOCARCINOMA; STOMACH CARCINOGENESIS; STOMACH CARCINOMA; SURVIVAL PREDICTION; SURVIVAL RATE; TIGHT JUNCTION; TISSUE DIFFERENTIATION; TUMOR DIFFERENTIATION;

ADENOCARCINOMA; ADULT; AGED; AGED, 80 AND OVER; CLAUDIN-4; FEMALE; FOLLOW-UP STUDIES; GASTRIC MUCOSA; HUMANS; IMMUNOENZYME TECHNIQUES; LYMPHATIC METASTASIS; MALE; METAPLASIA; MIDDLE AGED; NEOPLASM INVASIVENESS; NEOPLASM STAGING; PROGNOSIS; STOMACH NEOPLASMS; SURVIVAL RATE; TUMOR MARKERS, BIOLOGICAL;

EID: 84879802824     PISSN: None     EISSN: 14777819     Source Type: Journal    
DOI: 10.1186/1477-7819-11-150     Document Type: Article

References (43)

1. Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D. Global cancer statistics. CA Cancer J Clin 2011, 61:69-90. 10.3322/caac.20107, 21296855.
2. Correa P. Human gastric carcinogenesis: a multistep and multifactorial process-First American Cancer Society Award Lecture on Cancer Epidemiology and Prevention. Cancer Res 1992, 52:6735-6740.
3. Tsukita S, Furuse M, Itoh M. Multifunctional strands in tight junctions. Nat Rev Mol Cell Bio 2001, 2:285-293.
4. Gonzalez-Mariscal L, Betanzos A, Nava P, Jaramillo BE. Tight junction proteins. Prog Biophys Mol Biol 2003, 81:1-44. 10.1016/S0079-6107(02)00037-8, 12475568.
5. Matter K, Balda MS. Signalling to and from tight junctions. Nat Rev Mol Cell Biol 2003, 4:225-236.
6. Shin K, Fogg VC, Margolis B. Tight junctions and cell polarity. Annu Rev Cell Dev Biol 2006, 22:207-235. 10.1146/annurev.cellbio.22.010305.104219, 16771626.
7. Morin PJ. Claudin proteins in human cancer: promising new targets for diagnosis and therapy. Cancer Res 2005, 65:9603-9606. 10.1158/0008-5472.CAN-05-2782, 16266975.
8. Krause G, Winkler L, Mueller SL, Haseloff RF, Piontek J, Blasig IE. Structure and function of claudins. BiochimBiophysActa 2008, 1778:631-645.
9. Lal-Nag M, Morin PJ. The claudins. Genome Biol 2009, 10:235. 10.1186/gb-2009-10-8-235, 2745760, 19706201.
10. Ouban A, Ahmed AA. Claudins in human cancer: a review. Histol Histopathol 2010, 25:83-90.
11. Hewitt KJ, Agarwal R, Morin PJ. The claudin gene family: expression in normal and neoplastic tissues. BMC Cancer 2006, 6:186. 10.1186/1471-2407-6-186, 1538620, 16836752.
12. Wu YL, Zhang S, Wang GR, Chen YP. Expression transformation of claudin-1 in the process of gastric adenocarcinoma invasion. World J Gastroenterol 2008, 14:4943-4948. 10.3748/wjg.14.4943, 2739949, 18756604.
13. Resnick MB, Gavilanez M, Newton E, Konkin T, Bhattacharya B, Britt DE, Sabo E, Moss SF. Claudin expression in gastric adenocarcinomas: a tissue microarray study with prognostic correlation. Hum Pathol 2005, 36:886-892. 10.1016/j.humpath.2005.05.019, 16112005.
14. Soini Y, Tommola S, Helin H, Martikainen P. Claudins 1, 3, 4 and 5 in gastric carcinoma, loss of claudin expression associates with the diffuse subtype. Virchows Arch 2006, 448:52-58. 10.1007/s00428-005-0011-6, 16220299.
15. Jung H, Jun KH, Jung JH, Chin HM, Park WB. The expression of claudin-1, claudin-2, claudin-3, and claudin-4 in gastric cancer tissue. J Surg Res 2011, 167:e185-191. 10.1016/j.jss.2010.02.010, 20462599.
16. Aung PP, Mitani Y, Sanada Y, Nakayama H, Matsusaki K, Yasui W. Differential expression of claudin-2 in normal human tissues and gastrointestinal carcinomas. Virchows Arch 2006, 448:428-434. 10.1007/s00428-005-0120-2, 16328347.
17. Kuo WL, Lee LY, Wu CM, Wang CC, Yu JS, Liang Y, Lo CH, Huang KH, Hwang TL. Differential expression of claudin-4 between intestinal and diffuse-type gastric cancer. Oncol Rep 2006, 16:729-734.
18. Lee SK, Moon J, Park SW, Song SY, Chung JB, Kang JK. Loss of the tight junction protein claudin 4 correlates with histological growth-pattern and differentiation in advanced gastric adenocarcinoma. Oncol Rep 2005, 13:193-199.
19. Ohtani S, Terashima M, Satoh J, Soeta N, Saze Z, Kashimura S, Ohsuka F, Hoshino Y, Kogure M, Gotoh M. Expression of tight-junction-associated proteins in human gastric cancer: downregulation of claudin-4 correlates with tumor aggressiveness and survival. Gastric Cancer 2009, 12:43-51.
20. Rendon-Huerta E, Teresa F, Teresa GM, Xochitl GS, Georgina AF, Veronica ZZ, Montano LF. Distribution and expression pattern of claudins 6, 7, and 9 in diffuse- and intestinal-type gastric adenocarcinomas. J Gastrointest Cancer 2010, 41:52-59. 10.1007/s12029-009-9110-y, 19960275.
21. Johnson AH, Frierson HF, Zaika A, Powell SM, Roche J, Crowe S, Moskaluk CA, El-Rifai W. Expression of tight-junction protein claudin-7 is an early event in gastric tumorigenesis. Am J Pathol 2005, 167:577-584. 10.1016/S0002-9440(10)62999-9, 1603560, 16049341.
22. Sanada Y, Oue N, Mitani Y, Yoshida K, Nakayama H, Yasui W. Down-regulation of the claudin-18 gene, identified through serial analysis of gene expression data analysis, in gastric cancer with an intestinal phenotype. J Pathol 2006, 208:633-642. 10.1002/path.1922, 16435283.
23. Katoh M. CLDN23 gene, frequently down-regulated in intestinal-type gastric cancer, is a novel member of CLAUDIN gene family. Int J Mol Med 2003, 11:683-689.
24. Lee LY, Wu CM, Wang CC, Yu JS, Liang Y, Huang KH, Lo CH, Hwang TL. Expression of matrix metalloproteinases MMP-2 and MMP-9 in gastric cancer and their relation to claudin-4 expression. Histol Histopathol 2008, 23:515-521.
25. Agarwal R, D'Souza T, Morin PJ. Claudin-3 and claudin-4 expression in ovarian epithelial cells enhances invasion and is associated with increased matrix metalloproteinase-2 activity. Cancer Res 2005, 65:7378-7385. 10.1158/0008-5472.CAN-05-1036, 16103090.
26. Yao Q, Cao S, Li C, Mengesha A, Low P, Kong B, Dai S, Wei M. Turn a diarrhoea toxin into a receptor-mediated therapy for a plethora of CLDN-4-overexpressing cancers. Biochem Biophys Res Commun 2010, 398:413-419. 10.1016/j.bbrc.2010.06.089, 20599713.
27. Michl P, Buchholz M, Rolke M, Kunsch S, Lohr M, McClane B, Tsukita S, Leder G, Adler G, Gress TM. Claudin-4: a new target for pancreatic cancer treatment using Clostridium perfringens enterotoxin. Gastroenterology 2001, 121:678-684. 10.1053/gast.2001.27124, 11522752.
28. Kominsky SL, Vali M, Korz D, Gabig TG, Weitzman SA, Argani P, Sukumar S. Clostridium perfringens enterotoxin elicits rapid and specific cytolysis of breast carcinoma cells mediated through tight junction proteins claudin 3 and 4. Am J Pathol 2004, 164:1627-1633. 10.1016/S0002-9440(10)63721-2, 1615652, 15111309.
29. Edge SB, Compton CC. The American Joint Committee on cancer: the 7th edition of the AJCC cancer staging manual and the future of TNM. Ann Surg Oncol 2010, 17:1471-1474. 10.1245/s10434-010-0985-4, 20180029.
30. Hamilton SR, Aaltonen LA. Pathology and genetics of tumours of the digestive system.World Health Organization Classification of Tumours, vol. 2 2000, Lyon, France: IARC Press.
31. Sinicrope FA, Ruan SB, Cleary KR, Stephens LC, Lee JJ, Levin B. bcl-2 and p53 oncoprotein expression during colorectal tumorigenesis. Cancer Res 1995, 55:237-241.
32. Sung CO, Han SY, Kim SH. Low expression of claudin-4 is associated with poor prognosis in esophageal squamous cell carcinoma. Ann Surg Oncol 2011, 18:273-281. 10.1245/s10434-010-1289-4, 20839069.
33. Tierney JF, Stewart LA, Ghersi D, Burdett S, Sydes MR. Practical methods for incorporating summary time-to-event data into meta-analysis. Trials 2007, 8:16. 10.1186/1745-6215-8-16, 1920534, 17555582.
34. Kwon MJ, Kim SH, Jeong HM, Jung HS, Kim SS, Lee JE, Gye MC, Erkin OC, Koh SS, Choi YL, Park CK, Shin YK. Claudin-4 overexpression is associated with epigenetic derepression in gastric carcinoma. Lab Invest 2011, 91:1652-1667. 10.1038/labinvest.2011.117, 21844869.
35. Tokes AM, Kulka J, Paku S, Szik A, Paska C, Novak PK, Szilak L, Kiss A, Bogi K, Schaff Z. Claudin-1, -3 and -4 proteins and mRNA expression in benign and malignant breast lesions: a research study. Breast Cancer Res 2005, 7:R296-R305. 10.1186/bcr983, 1064136, 15743508.
36. Matsuda Y, Semba S, Ueda J, Fuku T, Hasuo T, Chiba H, Sawada N, Kuroda Y, Yokozaki H. Gastric and intestinal claudin expression at the invasive front of gastric carcinoma. Cancer Sci 2007, 98:1014-1019. 10.1111/j.1349-7006.2007.00490.x, 17459057.
37. Huo Q, Kinugasa T, Wang L, Huang J, Zhao J, Shibaguchi H, Kuroki M, Tanaka T, Yamashita Y, Nabeshima K, Iwasaki H. Claudin-1 protein is a major factor involved in the tumorigenesis of colorectal cancer. Anticancer Res 2009, 29:851-857.
38. Cunningham SC, Kamangar F, Kim MP, Hammoud S, Haque R, Iacobuzio-Donahue CA, Maitra A, Ashfaq R, Hustinx S, Heitmiller RE, Choti MA, Lillemoe KD, Cameron JL, Yeo CJ, Schulick RD, Montgomery E. Claudin-4, mitogen-activated protein kinase kinase 4, and stratifin are markers of gastric adenocarcinoma precursor lesions. Cancer Epidemiol Biomarkers Prev 2006, 15:281-287. 10.1158/1055-9965.EPI-05-0539, 16492916.
39. Furuse M, Furuse K, Sasaki H, Tsukita S. Conversion of zonulaeoccludentes from tight to leaky strand type by introducing claudin-2 into Madin-Darby canine kidney I cells. J Cell Biol 2001, 153:263-272. 10.1083/jcb.153.2.263, 2169456, 11309408.
40. Michl P, Barth C, Buchholz M, Lerch MM, Rolke M, Holzmann KH, Menke A, Fensterer H, Giehl K, Lohr M, Leder G, Iwamura T, Adler G, Gress TM. Claudin-4 expression decreases invasiveness and metastatic potential of pancreatic cancer. Cancer Res 2003, 63:6265-6271.
41. Ming SC. Gastric carcinoma. A pathobiological classification. Cancer 1977, 39:2475-2485. 10.1002/1097-0142(197706)39:6<2475::AID-CNCR2820390626>3.0.CO;2-L, 872047.
42. Japanese Gastric Cancer Association Japanese classification of gastric carcinoma: 3rd English edition. Gastric Cancer 2011, 14:101-112. Japanese Gastric Cancer Association.
43. Turksen K, Troy TC. Barriers built on claudins. J Cell Sci 2004, 117:2435-2447. 10.1242/jcs.01235, 15159449.